EUREKABIO
EurekaBio offers solutions for cancer immunotherapy including automatic cell therapy manufacturing equipment and a vector production platform
EUREKABIO
Industry:
Biotechnology Health Care Medical
Address:
Shenzhen, Guangdong, China
Country:
China
Website Url:
http://www.eurekabio.com
Status:
Active
Contact:
+86-755-86562586
Email Addresses:
[email protected]
Total Funding:
100 M CNY
Investors List
Eight Roads Ventures
Eight Roads Ventures investment in Series B - EurekaBio
Official Site Inspections
http://www.eurekabio.com
- Host name: catl.com
- IP address: 203.107.45.167
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "EurekaBio"
About EurekaBio｜EurekaBio
EurekaBio is a leading upstream core vendor in the field of Cell and Gene Therapy (CGT), focusing on innovative research and development of cutting-edge technologies and key equipment essential for advancing CGT. Solutions …See details»
EurekaBio - Crunchbase Company Profile & Funding
Organization. EurekaBio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. EurekaBio is …See details»
EurekaBio｜ Empower CGT
EurekaBio is a leading upstream core vendor in the field of Cell and Gene Therapy (CGT), focusing on innovative research and development of cutting-edge technologies and key …See details»
Our Story - EurekaBio
EurekaBio "Three fearless explorers, tackling the tough challenges" Driven by the mission of “Empowering CGT and Confronting Formidable Industry Challenges”, the three founders of EurekaBio established the company with a vision to cure …See details»
Eureka Bio 2025 Company Profile: Valuation, Funding …
Eureka Bio General Information Description. Provider and developer of cell therapy solutions designed for cancer treatment. The company focuses on automation medical equipment in the field of gene and cell therapy, enabling …See details»
Eurekabio - Products, Competitors, Financials, Employees, …
EurekaBio Raises $40M To Support Lentiviral Vector Platform. Mar 10, 2024. EurekaBio Raises $40M To Support Lentiviral Vector Platform Source: Key Topics in this News Article: News …See details»
EurekaBio - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Guangzhou Yuexiu Industrial …See details»
EurekaBio - Contacts, Employees, Board Members, Advisors
EurekaBio is a biotechnology company that offers solutions for cancer immunotherapy.See details»
Eurekabio - ATCG
Founded in 2014., Eurekabio is a scientific and technological enterprise focusing on the research and development of core technologies and processes in gene and cell therapy. We are committed to discovering innovative ways into the …See details»
A Brief History of EurekaBio – CANVAS, SWOT, PESTEL & BCG …
Dec 19, 2024 Founding and Origins of EurekaBio. EurekaBio was founded in 2015 by a team of passionate scientists and entrepreneurs with a shared vision of revolutionizing cancer …See details»
Mission, Vision & Core Values of EurekaBio
Dec 19, 2024 [cbm_blg_rlnkng]Welcome to EurekaBio, where innovation meets purpose. Our mission at EurekaBio is to revolutionize the way we approach healthcare through cutting-edge …See details»
深研生物 EurekaBio｜ Empower CGT
为了解决载体生产工艺的可靠性和生产放大这一难题，深研生物开发了eulv ® 基于稳定细胞系的慢病毒载体生产系统。 eulv ® 系统无需质粒转染的步骤，所有的包装基因以及目的基因都稳定 …See details»
EurekaBio and VectorBuilder Join Forces to Reduce Viral Vector ...
February 18, 2025 – A new chapter in cell & gene therapy begins today. Chicago, USA – VectorBuilder, a global expert in gene delivery technology, and EurekaBio, a leading upstream …See details»
Who Owns EurekaBio – CanvasBusinessModel.com
Dec 19, 2024 This move allowed EurekaBio to maintain its entrepreneurial spirit while benefiting from the resources and support of a larger organization. 5. Current Ownership Structure: …See details»
EurekaBio - Tech Stack, Apps, Patents & Trademarks - Crunchbase
The intellectual property of EurekaBio includes 7 registered patents primarily in the ' Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering ' …See details»
EurekaBio Completes $40 Million Series B+ Financing to Advance …
Mar 7, 2024 Shenzhen Eureka Biotechnology Co., Limited (EurekaBio), a leading upstream supplier in the cell and gene therapy field, announced the completion of its Series B+ …See details»
EurekaBio Completes $40 Million Series B+ Financing to Advance …
Mar 7, 2024 EurekaBio has brought forth advanced cellular drug production solutions and the EuLV™ lentiviral vector platform. These breakthroughs, including high-titer stable lentiviral …See details»
Chinese biotech startup EurekaBio raises $40 M to advance …
Mar 8, 2024 EurekaBio's core innovation lies in the EuLV Lentiviral Vector Production System, a cutting-edge technology that transforms the large-scale production of lentiviral vectors using …See details»
Applications - EurekaBio
EurekaBio is dedicated to developing fully closed and automated equipment that enhances cell preparation efficiency, mitigates contamination risks, streamlines process validation and …See details»
EuBioX System - EurekaBio
The EuLV™ system is a lentiviral vector stable producer cell line production system that utilizes inducible stable producer cell lines to produce lentiviral vectors via high-cell-density …See details»